Evidence map›Paper›PMID 39734577›Full record

ReviewFrontiers in chemistry2024

Novel transition metal-free synthetic protocols toward the construction of 2,3-dihydrobenzofurans: a recent update.

Aqsa Mushtaq, Muhammad Irfan, Atta Ul Haq, Asim Mansha, Samreen Gul Khan, Ameer Fawad Zahoor, Bushra Parveen, Ali Irfan, Katarzyna Kotwica-Mojzych, Mariola Glowacka and 1 more

Abstract readReview
In one paragraph

Review in Frontiers in chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Aqsa MushtaqDepartment of Chemistry, Government College University Faisalabad, Faisalabad, Pakistan.
Muhammad IrfanDepartment of Pharmaceutics, Government College University, Faisalabad, Pakistan.
Atta Ul HaqDepartment of Chemistry, Government College University Faisalabad, Faisalabad, Pakistan.
Asim ManshaDepartment of Chemistry, Government College University Faisalabad, Faisalabad, Pakistan.
Samreen Gul KhanDepartment of Chemistry, Government College University Faisalabad, Faisalabad, Pakistan.
Ameer Fawad ZahoorDepartment of Chemistry, Government College University Faisalabad, Faisalabad, Pakistan.
Bushra ParveenDepartment of Chemistry, Government College University Faisalabad, Faisalabad, Pakistan.
Ali IrfanDepartment of Chemistry, Government College University Faisalabad, Faisalabad, Pakistan.
Katarzyna Kotwica-MojzychDepartment of Basic Sciences, Department of Histology, Embriology and Cytophysiology, Medical University of Lublin, Lublin, Poland.
Mariola GlowackaFaculty of Health Sciences Collegium Medicum, The Mazovian Academy in Plock, Płock, Poland.
Mariusz MojzychFaculty of Health Sciences Collegium Medicum, The Mazovian Academy in Plock, Płock, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

2,3-Dihydrobenzofurans are noteworthy scaffolds in organic and medicinal chemistry, constituting the structural framework of many of the varied medicinally active organic compounds. Moreover, a diverse variety of biologically potent natural products also contain this heterocyclic nucleus. Reflecting on the wide biological substantiality of dihydrobenzofurans, several innovative and facile synthetic developments are evolving to achieve these heterocycles. This review summarizes the transition-metal-free, efficient, and novel synthetic pathways toward constructing the dihydrobenzofuran nucleus established after 2020.

Indexed as

catalyst freedihydrobenzofuransorganocatalyzedphotocatalytictransition metal-free

Identifiers

PMID39734577
PMCPMC11672212

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.